TechNOW podcast: Clever soles helping diabetics take safe strides
Dr Anna Hatton has come up with a way of making shoes high tech to help a diabetic better negotiate the road ahead.
Around one in 20 Australians suffers from diabetes.
High blood sugar can injure nerves and blood vessels throughout the body. And the first nerves to be affected tend to be the smallest ones, furthest away from the spinal cord – those that stretch to the toes and feet.
That nerve damage is called diabetic neuropathy and it can cause a tingling in the toes or a constant burning feeling in the feet. It can be sneaky too and completely rob the feet of their ability to sense pain.
But Dr Anna Hatton has come up with a way of making shoes high tech to help a diabetic better negotiate the road ahead.
TechNOW is a podcast about Australian innovations that are shaping the future, thanks to the Global Connections Fund.
Listen to the podcast
Watch a 30 second promo
More information
High-tech shoes that counter one of the most painful and debilitating effects of diabetes are being trialled, thanks to a collaboration between University of Queensland physiotherapy senior lecturer Dr Anna Hatton and UK-Danish health-tech company Walk With Path (WWP).
The latest phase of the project, in which prototype shoe insoles are tested by volunteers in the laboratory, was funded by a grant from the Global Connections Fund (GCF).
High blood sugar levels mean many people with diabetes suffer long-lasting nerve damage. The condition, known as diabetic peripheral neuropathy, occurs most often in feet and legs and results in numbness and pain.
In severe cases, patients have difficulty walking and are at increased risk of foot ulcers and injuries caused by falls.
Dr Hatton and WWP have developed app-controlled vibrating panels designed to fit inside shoes. These insoles, which contain custom-printed circuits allied with a range of sensors, provide robust and reliable feedback to wearers who are no longer able to rely on their own nervous systems.
The emitted vibrations enable people with diabetic neuropathy to better adjust to terrain in real time, helping them stabilise balance and gait, greatly reducing the risk of falls and injury. The devices also transmit data to a smart phone app, allowing users to analyse and adapt walking actions to further improve efficiency and safety.
“Since receiving the GCF bridging grant, we have advanced the design of a vibrating insole,” said Dr Hatton.
“We’ve been able to reduce the thickness of the insoles, and added a new material layer, which helps minimise foot ulcers.”
When ready for market, the system will be presented under the name PathFeel. Testing of the devices began through a University of Queensland trial in late 2019, with the first cohort of users reporting positive results.
“Our project marks the first step in creating a viable new treatment option to enhance balance and walking ability in adults with diabetic peripheral neuropathy, helping people to remain active and independent for longer,” said Dr Hatton. Dr Hatton and WWP are currently working on variations of vibratory insoles, experimenting with thickness, shape, water resistance and compliance with existing orthotics.
